Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This phase III trial compares hepatic arterial infusion (HAI) (pump chemotherapy) in addition to standard of care chemotherapy versus standard of care chemotherapy alone in treating patients with colorectal cancer that has spread to the liver (liver metastases) and cannot be removed by surgery (unresectable). HAI uses a catheter to carry a tumor-killing chemotherapy drug called floxuridine directly into the liver. HAI is already approved by the Food and Drug Administration (FDA) for use in metas
Sponsor: ECOG-ACRIN Cancer Research Group
Check if you qualify for this colorectal cancer clinical trial in Birmingham, AL
If you're searching for colorectal cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.